97 related articles for article (PubMed ID: 2836520)
1. Use of interleukin-2 and macrophages to treat herpes simplex virus infection in neonatal mice.
Kohl S; Loo LS
J Infect Dis; 1988 Jun; 157(6):1187-92. PubMed ID: 2836520
[TBL] [Abstract][Full Text] [Related]
2. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
Kohl S; Thomas JW; Loo LS
J Immunol; 1986 Apr; 136(8):3038-44. PubMed ID: 3007609
[TBL] [Abstract][Full Text] [Related]
3. Defective production of antibody to herpes simplex virus in neonates: defective production of T helper lymphokine and induction of suppression.
Kohl S; Cox PA; Loo LS
J Infect Dis; 1987 Jun; 155(6):1179-87. PubMed ID: 3033093
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism.
Kohl S; Loo LS; Drath DB; Cox P
J Infect Dis; 1989 Feb; 159(2):239-47. PubMed ID: 2492588
[TBL] [Abstract][Full Text] [Related]
5. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
6. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
Starr SE; Visintine AM; Tomeh MO; Nahmias AJ
Proc Soc Exp Biol Med; 1976 May; 152(1):57-60. PubMed ID: 177992
[TBL] [Abstract][Full Text] [Related]
7. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
Kohl S; Loo LS; Greenberg SB
J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
[No Abstract] [Full Text] [Related]
8. Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.
Kohl S; Drath DB; Loo LS
Infect Immun; 1982 Dec; 38(3):1231-41. PubMed ID: 6295943
[TBL] [Abstract][Full Text] [Related]
9. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
Kohl S
Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
[TBL] [Abstract][Full Text] [Related]
10. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
Kohl S
J Immunol; 1990 Jan; 144(1):307-12. PubMed ID: 2153165
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interleukin-1 alpha, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1.
Berkowitz C; Becker Y
Arch Virol; 1992; 124(1-2):83-93. PubMed ID: 1571022
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cytotoxicity and antibody-dependent cell cytotoxicity to herpes simplex virus-infected target cells in murine pregnancy.
Loftin KC; Gonik B; Kumaran P
Am J Reprod Immunol Microbiol; 1988 Jun; 17(2):53-6. PubMed ID: 2847568
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
14. X-linkage of the early in vitro alpha/beta interferon response of mouse peritoneal macrophages to herpes simplex virus type 2.
Ellermann-Eriksen S; Liberto MC; Iannello D; Mogensen SC
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1025-33. PubMed ID: 3011968
[TBL] [Abstract][Full Text] [Related]
15. Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection.
Bernstein DI; Loo LS; Kohl S
Antiviral Res; 1988 Dec; 10(6):279-87. PubMed ID: 2854958
[TBL] [Abstract][Full Text] [Related]
16. Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice.
Baron S; Worthington MG; Williams J; Gaines JW
Nature; 1976 Jun; 261(5560):505-6. PubMed ID: 180414
[No Abstract] [Full Text] [Related]
17. Immunotherapy and drugs in neonatal disseminated herpes simplex virus type 2 infections: a mouse model.
Strulovitch C; Marks MI; Soneji A; Goldberg S
J Antimicrob Chemother; 1979 Jul; 5(4):437-46. PubMed ID: 226512
[No Abstract] [Full Text] [Related]
18. Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells.
Kohl S; Loo LS
Infect Immun; 1980 Dec; 30(3):847-50. PubMed ID: 6262242
[TBL] [Abstract][Full Text] [Related]
19. Passive immunotherapy for encephalitis caused by herpes simplex virus.
Erlich KS; Mills J
Rev Infect Dis; 1986; 8 Suppl 4():S439-45. PubMed ID: 3018895
[TBL] [Abstract][Full Text] [Related]
20. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
